|Brainsway Ltd., of Jerusalem||Deep TMS system||Transcranial magnetic stimulation (TMS) device||For use as an aid in short-term smoking cessation in adults||Received 510(k) clearance from the U.S. FDA|
|Guardant Health Inc., of Redwood City, Calif.||Guardant-19||Reverse transcriptase polymerase chain reaction next-generation sequencing test||Detection of the novel coronavirus||U.S. FDA granted emergency use authorization|
|Helixbind, of Boxborough, Mass.||Rapid/BSI||First test for the Rapid platform||Identifies the most common bloodstream infections (BSIs) associated with sepsis||Awarded breakthrough device designation from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.